(Q34734126)

4 August 2017

1 reference

title

Role of chemotherapy in the management of ovarian cancer (English)

1 reference

4 August 2017

1 reference

1 reference

Maurie Markman

1

1 reference

4 August 2017

language of work or name

1 reference

1 February 2002

1 reference

Expert Review of Anticancer Therapy

4 August 2017

published in

1 reference

4 August 2017

volume

2

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

90-96

1 reference

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.90

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.90

Second-line treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.90

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.90

Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.90

A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: a Danish Ovarian Study Group trial (DACOVA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.90

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.90

Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.90

Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.90

Intraperitoneal therapy for treatment of malignant disease principally confined to the peritoneal cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2.1.90

21 January 2018

Identifiers

DOI

10.1586/14737140.2.1.90

1 reference

4 August 2017

1 reference